QA: Seelos Therapeutics INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2015_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 13,289,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,358,000
3 remainder_Assets 162,000
4 LiabilitiesCurrent 6,906,000
5 LiabilitiesNoncurrent 358,000
6 remainder_Liabilities 5,626,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,599,377
9 ResearchAndDevelopmentExpense 18,683,542
10 remainder_Expenses -642,812
11 remainder_Revenues 6,144,807
12 remainder_NetIncome 659,147
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,809,000
1 Liabilities 12,890,000
2 Expenses 28,640,107
3 Revenues 6,144,807
4 StockholdersEquity 1,919,000
5 NetIncome -21,836,153
6 ComprehensiveNetIncome -21,836,153
7 BaseVar 31,571,530
8 EconomicCapitalRatiobeforeLimitedLiability -1.27
9 EconomicCapitalRatio 1.24

Edgar->Model Mapping

Feature Distribution

Change over Time